α-Blockers for the treatment of chronic prostatitis in combination with antibiotics

Journal of Urology

Volumn 159, Issue 3, 1998, Pages 883-887

  Barbalias, George A ^a   Nikiforidis, George ^a   Liatsikos, Evagelos N ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Adrenergic alpha receptor blockaders; Antibiotics; Prostatitis; Urethral diseases

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; CIPROFLOXACIN; TERAZOSIN;

ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHRONIC PROSTATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; SYMPTOMATOLOGY;

EID: 0031882156     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63761-3     Document Type: Article

References (20)

1. Drach, G. W., Fair, W. R., Meares, E. M. and Stamey, T. A.: Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia (letter)? J. Urol., 120: 266, 1978.
2. Barbalias, G. A.: Prostatodynia or painful male urethral syndrome? Urology, 36: 146, 1990.
3. Meares, E. M. and Barbalias, G. A.: Prostatitis: bacterial, non-bacterial, and prostatodynia. Sem. Urol., 1: 146, 1983.
4. Barbalias, G. A., Meares, E. M. and Sant, G. R.: Prostatodynia: clinical and urodynamic characteristics. J. Urol., 130: 514, 1983.
5. Barbalias, G. A. and Blaivas, J. G.: Neurologic implications of the pathophysiologically open bladder neck. J. Urol., 129: 780, 1983.
6. Meares, E. M. and Stamey, T. A.: Bacteriological localization patterns in bacterial prostatitis and urethritis. Invest. Urol., 5: 492, 1968.
7. Neal, D. E. and Moon, T. D.: Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology, 43: 460, 1994.
8. Miller, J. L., Rothman, I., Bavendam, T. G. and Berger, R. E.: Prostatodynia and interstitial cystitis: one and the same? Urology, 45: 587, 1995.
9. Doble, A., Harris, J. R. W. and Taylor-Robinson, D.: Prostatodynia and herpes simplex virus infection. Urology, 38: 247, 1991.
10. Blacklock, N. J. and Beavis, J. P.: The response of prostatic fluid pH in inflammation. Brit. J. Urol., 46: 537, 1974.
11. Anderson, R. U. and Weller, C.: Prostatic secretion leucocyte studies in non-bacterial prostatitis (prostatosis). J. Urol., 121: 292, 1979.
12. Schaeffer, A. J., Wendel, E. F., Dunn, J. K. and Grayhack, J. T.: Prevalence and significance of prostatic inflammation. J. Urol., 125: 215, 1981.
13. Brunner, H., Weidner, W. and Schiefer, H. G.: Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J. Infect. Dis., 147: 807, 1983.
14. Donker, P. J., Ivanovici, F. and Noach, E. L.: Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Brit. J. Urol., 44: 180, 1972.
15. Awad, S. A. and Downie, J. W.: Sympathetic dyssynergia in the region of the external sphincter: a possible source of lower urinary tract obstruction. J. Urol., 118: 636, 1977.
16. Lowentritt, J. E., Kawahara, K., Human, L. G., Hellstrom, W. J. G. and Domingue, G. J.: Bacterial infection in prostatodynia. J. Urol., 154: 1378, 1995.
17. Nickel, J. C. and Costerton, J. W.: Coagulase-negative staphylococcus in chronic prostatitis. J. Urol., 147: 398, 1992.
18. Wedren, H.: On chronic prostatitis with special studies of staphylococcus epidermidis. Scand. J. Urol. Nephrol., suppl., 123: 1, 1989.
19. Shortliffe, L. M. D., Sellers, R. G. and Schachter, J.: The characterization of nonbacterial prostatitis: search for an etiology. J. Urol., 148: 1461, 1992.
20. Meares, E. M., Jr.: Prostatodynia: clinical findings and rationale for treatment. In: Therapy of Prostatitis. Edited by W. Weidner, H. Brunner, W. Krause and C. F. Rothauge. San Francisco: W. Zuckschwerdt Verlag, vol. 11, pp. 207-212, 1986.